Multi-Target Metabolic Therapies Creating New Momentum in the...

added blog Networking

2026-06-15 05:57:06 - Translate -

Multi-Target Metabolic Therapies Creating New Momentum in the Triple Agonist Drug Market

According to the latest report published by Data Bridge Market Research, the Triple Agonist (GLP-1/GIP/Glucagon) Drug Market CAGR Value The global triple agonist (GLP-1/GIP/Glucagon) drug market size was valued at USD 2.68 billion in 2025and is expected to reach USD 10.42 billion by 2033, at a CAGR of 18.50% during the forecast period DBMR team uses simple language and easy...

0 Comments 0 Shares 31 Views 0 Reviews